6-fluoro-4-oxo-7-[3-(prop-2-ynylcarbamoyl)azetidin-1-yl]-1-(1,3-thiazol-2-yl)-1,8-naphthyridine-3-carboxylic acid

C19H14FN5O4S — CID 142434794

IUPAC6-fluoro-4-oxo-7-[3-(prop-2-ynylcarbamoyl)azetidin-1-yl]-1-(1,3-thiazol-2-yl)-1,8-naphthyridine-3-carboxylic acid
SMILESC#CCNC(=O)C1CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3-c2nccs2)C1
InChIInChI=1S/C19H14FN5O4S/c1-2-3-21-17(27)10-7-24(8-10)16-13(20)6-11-14(26)12(18(28)29)9-25(15(11)23-16)19-22-4-5-30-19/h1,4-6,9-10H,3,7-8H2,(H,21,27)(H,28,29)
InChIKeyVHPAXSLACPTLAE-UHFFFAOYSA-N
MW427.42 g/mol
LogP0.87
Rot. Bonds5

About 6-fluoro-4-oxo-7-[3-(prop-2-ynylcarbamoyl)azetidin-1-yl]-1-(1,3-thiazol-2-yl)-1,8-naphthyridine-3-carboxylic acid

6-fluoro-4-oxo-7-[3-(prop-2-ynylcarbamoyl)azetidin-1-yl]-1-(1,3-thiazol-2-yl)-1,8-naphthyridine-3-carboxylic acid (PubChem CID 142434794) has the molecular formula C19H14FN5O4S and a molecular weight of 427.42 g/mol. Its IUPAC name is 6-fluoro-4-oxo-7-[3-(prop-2-ynylcarbamoyl)azetidin-1-yl]-1-(1,3-thiazol-2-yl)-1,8-naphthyridine-3-carboxylic acid.

Molecular Properties

Compound Name6-fluoro-4-oxo-7-[3-(prop-2-ynylcarbamoyl)azetidin-1-yl]-1-(1,3-thiazol-2-yl)-1,8-naphthyridine-3-carboxylic acid
PubChem CID142434794
Molecular FormulaC19H14FN5O4S
Molecular Weight427.42 g/mol
Exact Mass427.08
IUPAC Name6-fluoro-4-oxo-7-[3-(prop-2-ynylcarbamoyl)azetidin-1-yl]-1-(1,3-thiazol-2-yl)-1,8-naphthyridine-3-carboxylic acid
SMILESC#CCNC(=O)C1CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3-c2nccs2)C1
InChIInChI=1S/C19H14FN5O4S/c1-2-3-21-17(27)10-7-24(8-10)16-13(20)6-11-14(26)12(18(28)29)9-25(15(11)23-16)19-22-4-5-30-19/h1,4-6,9-10H,3,7-8H2,(H,21,27)(H,28,29)
InChIKeyVHPAXSLACPTLAE-UHFFFAOYSA-N
XLogP0.87
TPSA117.42 Ų
H-Bond Donors2
H-Bond Acceptors8
Rotatable Bonds5
Heavy Atoms30
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500427.42
LogP ≤ 50.87
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 108

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze 6-fluoro-4-oxo-7-[3-(prop-2-ynylcarbamoyl)azetidin-1-yl]-1-(1,3-thiazol-2-yl)-1,8-naphthyridine-3-carboxylic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 6-fluoro-4-oxo-7-[3-(prop-2-ynylcarbamoyl)azetidin-1-yl]-1-(1,3-thiazol-2-yl)-1,8-naphthyridine-3-carboxylic acid?
The IUPAC name of 6-fluoro-4-oxo-7-[3-(prop-2-ynylcarbamoyl)azetidin-1-yl]-1-(1,3-thiazol-2-yl)-1,8-naphthyridine-3-carboxylic acid (CID 142434794) is 6-fluoro-4-oxo-7-[3-(prop-2-ynylcarbamoyl)azetidin-1-yl]-1-(1,3-thiazol-2-yl)-1,8-naphthyridine-3-carboxylic acid.
What is the SMILES notation for 6-fluoro-4-oxo-7-[3-(prop-2-ynylcarbamoyl)azetidin-1-yl]-1-(1,3-thiazol-2-yl)-1,8-naphthyridine-3-carboxylic acid?
The canonical SMILES for 6-fluoro-4-oxo-7-[3-(prop-2-ynylcarbamoyl)azetidin-1-yl]-1-(1,3-thiazol-2-yl)-1,8-naphthyridine-3-carboxylic acid is C#CCNC(=O)C1CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3-c2nccs2)C1.
What is the InChIKey of 6-fluoro-4-oxo-7-[3-(prop-2-ynylcarbamoyl)azetidin-1-yl]-1-(1,3-thiazol-2-yl)-1,8-naphthyridine-3-carboxylic acid?
The InChIKey is VHPAXSLACPTLAE-UHFFFAOYSA-N. The full InChI is InChI=1S/C19H14FN5O4S/c1-2-3-21-17(27)10-7-24(8-10)16-13(20)6-11-14(26)12(18(28)29)9-25(15(11)23-16)19-22-4-5-30-19/h1,4-6,9-10H,3,7-8H2,(H,21,27)(H,28,29).
What are the key properties of 6-fluoro-4-oxo-7-[3-(prop-2-ynylcarbamoyl)azetidin-1-yl]-1-(1,3-thiazol-2-yl)-1,8-naphthyridine-3-carboxylic acid?
6-fluoro-4-oxo-7-[3-(prop-2-ynylcarbamoyl)azetidin-1-yl]-1-(1,3-thiazol-2-yl)-1,8-naphthyridine-3-carboxylic acid has a molecular weight of 427.42 g/mol, XLogP of 0.87, 5 rotatable bonds, 2 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 6-fluoro-4-oxo-7-[3-(prop-2-ynylcarbamoyl)azetidin-1-yl]-1-(1,3-thiazol-2-yl)-1,8-naphthyridine-3-carboxylic acid is sourced from PubChem (CID 142434794), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).